System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live1m

Terminal Asset View

stockNASDAQ

DNTH

$77.86-3.06%

Dianthus Therapeutics Inc

Too-Late

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

50Too-Late

Live Analysis Active

Company Mission

Dianthus Therapeutics creates special antibody medicines designed to treat autoimmune diseases where the body's immune system attacks healthy cells. These experimental drugs are being tested in clinical trials with patients who have conditions like lupus or rheumatoid arthritis. The company makes money through research partnerships with larger pharmaceutical companies and could earn future revenue if its drugs receive approval and are sold to patients.

DNT

Industry Context

The biotech industry focuses on developing new medical treatments through scientific research. Companies in this space often see their stock prices move significantly based on news about their experimental drugs, especially when clinical trial results are announced. This creates a high-risk, high-reward environment where investors watch for scientific breakthroughs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

31Matrix

Market Momentum

70.2— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.8x— Normal Volume

Today's Change

-3.06%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing DNTH across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 06:01 PM UTC

As-of 03-15-2026 17:46 UTC

Develops antibody drugs for autoimmune diseases and makes money by selling treatments to hospitals and clinics.

Weekly price swings are getting smaller, suggesting the stock is coiling tighter before a potential larger move.

Biotech sector volatility often increases during clinical trial results, which could impact this company's stock price near key announcements.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...